BioPharmSignal logoBioPharmSignal

Biotech News

Materialise rapporteert resultaten eerste kwartaal 2026

Materialise (MTLS)MaterialiseCompany update

Materialise draagt eyewear activiteiten over aan het management team Gereglementeerde informatie [1] LEUVEN, België — 7 mei 2026 — Materialise NV (Euronext & NASDAQ: MTLS), een wereldwijde leider in 3D-geprinte medische hulpmiddelen en software en een pionier in additive manufacturing‑software en

Related news

MTLSMaterialise2026-08-13 10:45 EST

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

MTLSMaterialise2026-07-27 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-08-13 10:45 EST

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

MTLSMaterialise2026-07-27 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-27 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

Stock data

Close
6.61 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States